• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硬皮病和人类免疫缺陷病毒感染相关肺动脉高压中丛状病变的发病机制与演变

Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection.

作者信息

Cool C D, Kennedy D, Voelkel N F, Tuder R M

机构信息

Department of Pathology, University of Colorado Health Sciences Center, Denver 80262, USA.

出版信息

Hum Pathol. 1997 Apr;28(4):434-42. doi: 10.1016/s0046-8177(97)90032-0.

DOI:10.1016/s0046-8177(97)90032-0
PMID:9104943
Abstract

Patients with primary pulmonary hypertension develop vascular lesions characterized by proliferated blood channels, the so-called plexiform lesions. These lesions are often associated with concentric intimal obliteration of pulmonary vessels. We report that the lungs of three patients with scleroderma-associated pulmonary hypertension showed a predominance of obliterative-concentric lesions, with relatively few plexiform or combined lesions. In contrast, plexiform lesions predominated in the lungs obtained from three patients with human immunodeficiency virus (HIV)-associated pulmonary hypertension; pure obliterative-concentric lesions were infrequent. Both plexiform and concentric obliterative lesions stained strongly positive for the endothelial cell marker factor VIII-related antigen. Muscle-specific actin immunostaining highlighted the smooth muscle cells of the tunica media of plexiform vessels, but not the luminal layers of the concentric-obliterative lesions. Proliferating cells, as determined by immunostaining with the MIB-1 antibody, were only detected in the plexiform vascular lesions. We postulate that concentric-obliterative lesions and plexiform lesions are temporally and etiologically related. A scaffolding of proliferating endothelial cells could be the common denominator of both lesions. Our hypothesis that there exists a chronological continuum, proceeding from early, proliferative plexiform lesions to late, nonproliferative concentric-obliterative lesions in primary and secondary pulmonary hypertension, may lead to better targeted treatment strategies and disease classification.

摘要

原发性肺动脉高压患者会出现以血管通道增生为特征的血管病变,即所谓的丛状病变。这些病变常伴有肺血管的同心性内膜闭塞。我们报告,三名硬皮病相关性肺动脉高压患者的肺部显示以闭塞性同心性病变为主,丛状或混合性病变相对较少。相比之下,三名人类免疫缺陷病毒(HIV)相关性肺动脉高压患者的肺部以丛状病变为主;单纯的闭塞性同心性病变很少见。丛状病变和同心性闭塞性病变的内皮细胞标记因子VIII相关抗原染色均呈强阳性。肌肉特异性肌动蛋白免疫染色突出了丛状血管中膜的平滑肌细胞,但未突出同心性闭塞性病变的管腔层。通过MIB-1抗体免疫染色确定的增殖细胞仅在丛状血管病变中检测到。我们推测同心性闭塞性病变和丛状病变在时间和病因上相关。增殖的内皮细胞支架可能是两种病变的共同特征。我们的假设是,在原发性和继发性肺动脉高压中,存在一个从早期增殖性丛状病变到晚期非增殖性同心性闭塞性病变的时间连续过程,这可能会导致更好的靶向治疗策略和疾病分类。

相似文献

1
Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection.硬皮病和人类免疫缺陷病毒感染相关肺动脉高压中丛状病变的发病机制与演变
Hum Pathol. 1997 Apr;28(4):434-42. doi: 10.1016/s0046-8177(97)90032-0.
2
Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth.使用细胞特异性标记物对丛状肺动脉高压中的肺动脉进行三维重建。肺内皮细胞生长动态异质性过程的证据。
Am J Pathol. 1999 Aug;155(2):411-9. doi: 10.1016/S0002-9440(10)65137-1.
3
Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.肺动脉高压的丛状病变中存在旺盛的内皮细胞生长和炎症成分。
Am J Pathol. 1994 Feb;144(2):275-85.
4
Vascular smooth muscle cell phenotypes in primary pulmonary hypertension.原发性肺动脉高压中的血管平滑肌细胞表型
Eur Respir J. 2001 Feb;17(2):316-20. doi: 10.1183/09031936.01.17203160.
5
Modulation of Intersectin-1s Lung Expression Induces Obliterative Remodeling and Severe Plexiform Arteriopathy in the Murine Pulmonary Vascular Bed.Intersectin-1s在肺中表达的调节可诱导小鼠肺血管床发生闭塞性重塑和严重的丛状动脉病变。
Am J Pathol. 2017 Mar;187(3):528-542. doi: 10.1016/j.ajpath.2016.11.012. Epub 2017 Jan 6.
6
Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension.重度肺动脉高压发病机制中的细胞和分子机制。
Eur Respir J. 1995 Dec;8(12):2129-38. doi: 10.1183/09031936.95.08122129.
7
Resistin-like molecule-beta in scleroderma-associated pulmonary hypertension.硬皮病相关肺动脉高压中的抵抗素样分子β
Am J Respir Cell Mol Biol. 2009 Nov;41(5):553-61. doi: 10.1165/rcmb.2008-0271OC. Epub 2009 Feb 27.
8
Lung structural remodeling and pulmonary hypertension after myocardial infarction: complete reversal with irbesartan.心肌梗死后的肺结构重塑与肺动脉高压:厄贝沙坦可使其完全逆转
Cardiovasc Res. 2003 Jun 1;58(3):621-31. doi: 10.1016/s0008-6363(03)00290-6.
9
Immunohistochemical examination of plexiform-like complex vascular lesions in the lungs of broiler chickens selected for susceptibility to idiopathic pulmonary arterial hypertension.免疫组织化学检查易发性特发性肺动脉高压肉鸡肺的丛状样复杂血管病变。
Avian Pathol. 2012;41(2):211-9. doi: 10.1080/03079457.2012.663077.
10
Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α.内皮细胞和造血细胞中脯氨酰-4-羟化酶2(PHD2)缺乏通过缺氧诱导因子-2α在小鼠和人类中引发闭塞性血管重塑和严重肺动脉高压。
Circulation. 2016 Jun 14;133(24):2447-58. doi: 10.1161/CIRCULATIONAHA.116.021494. Epub 2016 Apr 25.

引用本文的文献

1
Therapeutic effects of Gunryeong-tang on the cardio-renal axis in an animal model of pulmonary hypertension.葶苈汤对肺动脉高压动物模型心肾轴的治疗作用
Integr Med Res. 2025 Dec;14(4):101218. doi: 10.1016/j.imr.2025.101218. Epub 2025 Aug 7.
2
Human Pulmonary Artery Endothelial Cells Increased Glycolysis and Decreased Nitric Oxide Synthase O-GlcNAcylation in Pulmonary Arterial Hypertension.人肺动脉内皮细胞在肺动脉高压中糖酵解增加且一氧化氮合酶O-连接N-乙酰葡糖胺化减少。
Int J Transl Med (Basel). 2024 Mar;4(1):140-151. doi: 10.3390/ijtm4010007. Epub 2024 Feb 2.
3
Dendritic cell heterogeneity and its role in connective tissue diseases.
树突状细胞的异质性及其在结缔组织疾病中的作用。
Inflamm Regen. 2025 Jul 28;45(1):24. doi: 10.1186/s41232-025-00388-z.
4
The role of immune cells in the pathogenesis of connective tissue diseases-associated pulmonary arterial hypertension.免疫细胞在结缔组织病相关肺动脉高压发病机制中的作用。
Front Immunol. 2024 Sep 17;15:1464762. doi: 10.3389/fimmu.2024.1464762. eCollection 2024.
5
Periodontitis exacerbates pulmonary hypertension by promoting IFNγ T cell infiltration in mice.牙周炎通过促进 IFNγ T 细胞浸润加剧小鼠肺动脉高压。
Int J Oral Sci. 2024 Mar 28;16(1):27. doi: 10.1038/s41368-024-00291-2.
6
Phoenixin 20 ameliorates pulmonary arterial hypertension via inhibiting inflammation and oxidative stress.凤凰素 20 通过抑制炎症和氧化应激改善肺动脉高压。
Aging (Albany NY). 2024 Mar 19;16(6):5027-5037. doi: 10.18632/aging.205468.
7
Clinical-radiological-pathological correlation in pulmonary arterial hypertension.肺动脉高压的临床-放射-病理相关性。
Eur Respir Rev. 2023 Dec 20;32(170). doi: 10.1183/16000617.0138-2023. Print 2023 Dec 31.
8
Pharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension.肺动脉高压治疗中沙利鲁替尼的药理学和原理。
Int J Mol Sci. 2023 Aug 10;24(16):12653. doi: 10.3390/ijms241612653.
9
Pathophysiology and pathogenic mechanisms of pulmonary hypertension: role of membrane receptors, ion channels, and Ca signaling.肺动脉高压的病理生理学和发病机制:膜受体、离子通道和 Ca 信号的作用。
Physiol Rev. 2023 Jul 1;103(3):1827-1897. doi: 10.1152/physrev.00030.2021. Epub 2022 Nov 24.
10
Aggressive combination therapy for treatment of systemic sclerosis-associated pulmonary hypertension.积极联合治疗系统性硬化症相关肺动脉高压。
J Scleroderma Relat Disord. 2018 Feb;3(1):30-38. doi: 10.1177/2397198318758422. Epub 2018 Apr 4.